Cargando…
Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC
SIMPLE SUMMARY: According to guidelines from the European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Diseases (AASLD), abdominal ultrasound (US) is recommended for surveillance of hepatocellular carcinoma (HCC) in high-risk patients. However, US is...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405909/ https://www.ncbi.nlm.nih.gov/pubmed/36010954 http://dx.doi.org/10.3390/cancers14163961 |
_version_ | 1784773993189867520 |
---|---|
author | Willemssen, François de Lussanet de la Sablonière, Quido Bos, Daniel IJzermans, Jan De Man, Robert Dwarkasing, Roy |
author_facet | Willemssen, François de Lussanet de la Sablonière, Quido Bos, Daniel IJzermans, Jan De Man, Robert Dwarkasing, Roy |
author_sort | Willemssen, François |
collection | PubMed |
description | SIMPLE SUMMARY: According to guidelines from the European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Diseases (AASLD), abdominal ultrasound (US) is recommended for surveillance of hepatocellular carcinoma (HCC) in high-risk patients. However, US is limited as a surveillance modality for various reasons. Magnetic resonance imaging (MRI) is generally considered a better modality for detection of early HCC, but too elaborate in a surveillance setting. Consequently, abbreviated MRI (AMRI) protocols are investigated for surveillance purposes. The aim of our study was to evaluate the potential of non-contrast-enhanced AMRI (NC-AMRI) for surveillance of HCC, using multiple readers to investigate inter-observer agreement and the added value of double reading. We found that NC-AMRI presents a valuable screening tool for HCC and that double reading improves the sensitivity and specificity of HCC detection. ABSTRACT: Purpose: To evaluate NC-AMRI for the detection of HCC in high-risk patients. Methods: Patients who underwent yearly contrast-enhanced MRI (i.e., full MRI protocol) of the liver were included retrospectively. For all patients, the sequences that constitute the NC-AMRI protocol, namely diffusion-weighted imaging (DWI), T2-weighted (T2W) imaging with fat saturation, and T1-weighted (T1W) in-phase and opposed-phase imaging, were extracted, anonymized, and uploaded to a separate research server and reviewed independently by three radiologists with different levels of experience. Reader I and III held a mutual training session. Levels of suspicion of HCC per patient were compared and the sensitivity, specificity, and area under the curve (AUC) using the Mann–Whitney U test were calculated. The reference standard was a final diagnosis based on full liver MRI and clinical follow-up information. Results: Two-hundred-and-fifteen patients were included, 36 (16.7%) had HCC and 179 (83.3%) did not. The level of agreement between readers was reasonable to good and concordant with the level of expertise and participation in a mutual training session. Receiver operating characteristics (ROC) analysis showed relatively high AUC values (range 0.89–0.94). Double reading showed increased sensitivity of 97.2% and specificity of 87.2% compared with individual results (sensitivity 80.1%–91.7%–97.2%; specificity 91.1%–72.1%–82.1%). Only one HCC (2.8%) was missed by all readers. Conclusion: NC-AMRI presents a good potential surveillance imaging tool for the detection of HCC in high-risk patients. The best results are achieved with two observers after a mutual training session. |
format | Online Article Text |
id | pubmed-9405909 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94059092022-08-26 Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC Willemssen, François de Lussanet de la Sablonière, Quido Bos, Daniel IJzermans, Jan De Man, Robert Dwarkasing, Roy Cancers (Basel) Article SIMPLE SUMMARY: According to guidelines from the European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Diseases (AASLD), abdominal ultrasound (US) is recommended for surveillance of hepatocellular carcinoma (HCC) in high-risk patients. However, US is limited as a surveillance modality for various reasons. Magnetic resonance imaging (MRI) is generally considered a better modality for detection of early HCC, but too elaborate in a surveillance setting. Consequently, abbreviated MRI (AMRI) protocols are investigated for surveillance purposes. The aim of our study was to evaluate the potential of non-contrast-enhanced AMRI (NC-AMRI) for surveillance of HCC, using multiple readers to investigate inter-observer agreement and the added value of double reading. We found that NC-AMRI presents a valuable screening tool for HCC and that double reading improves the sensitivity and specificity of HCC detection. ABSTRACT: Purpose: To evaluate NC-AMRI for the detection of HCC in high-risk patients. Methods: Patients who underwent yearly contrast-enhanced MRI (i.e., full MRI protocol) of the liver were included retrospectively. For all patients, the sequences that constitute the NC-AMRI protocol, namely diffusion-weighted imaging (DWI), T2-weighted (T2W) imaging with fat saturation, and T1-weighted (T1W) in-phase and opposed-phase imaging, were extracted, anonymized, and uploaded to a separate research server and reviewed independently by three radiologists with different levels of experience. Reader I and III held a mutual training session. Levels of suspicion of HCC per patient were compared and the sensitivity, specificity, and area under the curve (AUC) using the Mann–Whitney U test were calculated. The reference standard was a final diagnosis based on full liver MRI and clinical follow-up information. Results: Two-hundred-and-fifteen patients were included, 36 (16.7%) had HCC and 179 (83.3%) did not. The level of agreement between readers was reasonable to good and concordant with the level of expertise and participation in a mutual training session. Receiver operating characteristics (ROC) analysis showed relatively high AUC values (range 0.89–0.94). Double reading showed increased sensitivity of 97.2% and specificity of 87.2% compared with individual results (sensitivity 80.1%–91.7%–97.2%; specificity 91.1%–72.1%–82.1%). Only one HCC (2.8%) was missed by all readers. Conclusion: NC-AMRI presents a good potential surveillance imaging tool for the detection of HCC in high-risk patients. The best results are achieved with two observers after a mutual training session. MDPI 2022-08-17 /pmc/articles/PMC9405909/ /pubmed/36010954 http://dx.doi.org/10.3390/cancers14163961 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Willemssen, François de Lussanet de la Sablonière, Quido Bos, Daniel IJzermans, Jan De Man, Robert Dwarkasing, Roy Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC |
title | Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC |
title_full | Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC |
title_fullStr | Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC |
title_full_unstemmed | Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC |
title_short | Potential of a Non-Contrast-Enhanced Abbreviated MRI Screening Protocol (NC-AMRI) in High-Risk Patients under Surveillance for HCC |
title_sort | potential of a non-contrast-enhanced abbreviated mri screening protocol (nc-amri) in high-risk patients under surveillance for hcc |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405909/ https://www.ncbi.nlm.nih.gov/pubmed/36010954 http://dx.doi.org/10.3390/cancers14163961 |
work_keys_str_mv | AT willemssenfrancois potentialofanoncontrastenhancedabbreviatedmriscreeningprotocolncamriinhighriskpatientsundersurveillanceforhcc AT delussanetdelasablonierequido potentialofanoncontrastenhancedabbreviatedmriscreeningprotocolncamriinhighriskpatientsundersurveillanceforhcc AT bosdaniel potentialofanoncontrastenhancedabbreviatedmriscreeningprotocolncamriinhighriskpatientsundersurveillanceforhcc AT ijzermansjan potentialofanoncontrastenhancedabbreviatedmriscreeningprotocolncamriinhighriskpatientsundersurveillanceforhcc AT demanrobert potentialofanoncontrastenhancedabbreviatedmriscreeningprotocolncamriinhighriskpatientsundersurveillanceforhcc AT dwarkasingroy potentialofanoncontrastenhancedabbreviatedmriscreeningprotocolncamriinhighriskpatientsundersurveillanceforhcc |